The Clorox Company (CLX) Income Statement Analysis

See more : NovAccess Global Inc. (XSNX) Income Statement Analysis – Financial Results

Complete financial analysis of The Clorox Company (CLX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Clorox Company, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.

You may be interested

The Clorox Company (CLX)

Industry: Household & Personal Products

Sector: Consumer Defensive

Website: https://www.thecloroxcompany.com

About The Clorox Company

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. The Clorox Company sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The company was founded in 1913 and is headquartered in Oakland, California.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991	1990	1989	1988	1987	1986
Revenue	7.09B	7.39B	7.11B	7.34B	6.72B	6.21B	6.12B	5.97B	5.76B	5.66B	5.59B	5.62B	5.47B	5.23B	5.53B	5.45B	5.27B	4.85B	4.64B	4.39B	4.32B	4.14B	4.06B	3.90B	4.08B	4.00B	2.74B	2.53B	2.22B	1.98B	1.84B	1.63B	1.72B	1.65B	1.48B	1.36B	1.26B	1.13B	1.09B
Cost of Revenue	4.05B	4.48B	4.56B	4.14B	3.66B	3.49B	3.45B	3.30B	3.16B	3.19B	3.23B	3.21B	3.16B	2.96B	3.06B	3.10B	3.10B	2.76B	2.69B	2.49B	2.39B	2.23B	2.31B	2.32B	2.05B	1.78B	1.05B	997.10M	890.70M	788.30M	726.30M	641.20M	689.30M	691.90M	655.30M	597.50M	541.80M	498.70M	498.00M
Gross Profit	3.05B	2.91B	2.55B	3.20B	3.06B	2.73B	2.68B	2.67B	2.60B	2.47B	2.36B	2.41B	2.30B	2.27B	2.48B	2.35B	2.18B	2.09B	1.96B	1.90B	1.94B	1.92B	1.75B	1.58B	2.03B	2.22B	1.69B	1.54B	1.33B	1.20B	1.11B	993.00M	1.03B	954.60M	828.70M	758.80M	718.10M	627.30M	591.10M
Gross Profit Ratio	42.97%	39.36%	35.81%	43.58%	45.57%	43.90%	43.68%	44.72%	45.10%	43.59%	42.21%	42.90%	42.14%	43.45%	44.76%	43.05%	41.25%	43.14%	42.18%	43.19%	44.80%	46.31%	43.17%	40.58%	49.82%	55.46%	61.52%	60.63%	59.84%	60.27%	60.46%	60.76%	59.85%	57.98%	55.84%	55.95%	57.00%	55.71%	54.27%
Research & Development	126.00M	138.00M	132.00M	149.00M	145.00M	136.00M	132.00M	135.00M	141.00M	136.00M	125.00M	130.00M	121.00M	115.00M	119.00M	114.00M	111.00M	108.00M	99.00M	88.00M	84.00M	76.00M	67.00M	67.00M	63.00M	62.00M	56.00M	50.50M	45.80M	44.80M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	1.17B	1.18B	954.00M	1.00B	969.00M	856.00M	837.00M	810.00M	806.00M	798.00M	765.00M	807.00M	798.00M	735.00M	747.00M	715.00M	690.00M	642.00M	631.00M	551.00M	552.00M	532.00M	537.00M	495.00M	525.00M	554.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	832.00M	734.00M	709.00M	790.00M	675.00M	612.00M	570.00M	599.00M	587.00M	523.00M	504.00M	500.00M	482.00M	502.00M	518.00M	499.00M	486.00M	474.00M	450.00M	435.00M	429.00M	456.00M	397.00M	352.00M	371.00M	357.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	2.00B	1.92B	1.66B	1.79B	1.64B	1.47B	1.41B	1.41B	1.39B	1.32B	1.27B	1.31B	1.28B	1.24B	1.27B	1.21B	1.18B	1.12B	1.08B	986.00M	981.00M	988.00M	934.00M	847.00M	990.00M	1.28B	954.70M	892.30M	749.80M	688.10M	690.70M	613.10M	682.00M	754.90M	562.10M	507.40M	473.40M	422.10M	389.90M
Other Expenses	0.00	-80.00M	-37.00M	72.00M	10.00M	-3.00M	3.00M	-6.00M	7.00M	13.00M	-2.00M	-6.00M	1.00M	-4.00M	0.00	0.00	0.00	0.00	0.00	4.00M	0.00	0.00	0.00	60.00M	201.00M	202.00M	137.60M	126.40M	116.50M	103.90M	94.10M	83.60M	89.60M	87.00M	50.10M	44.70M	37.50M	31.40M	27.10M
Operating Expenses	3.05B	2.06B	1.80B	1.94B	1.79B	1.60B	1.54B	1.54B	1.53B	1.46B	1.39B	1.44B	1.40B	1.35B	1.41B	1.33B	1.29B	1.22B	1.18B	1.08B	1.07B	1.06B	1.00B	974.00M	1.25B	1.54B	1.15B	1.07B	912.10M	836.80M	784.80M	696.70M	771.60M	841.90M	612.20M	552.10M	510.90M	453.50M	417.00M
Cost & Expenses	6.18B	6.54B	6.36B	6.09B	5.45B	5.09B	4.99B	4.85B	4.70B	4.65B	4.63B	4.65B	4.57B	4.31B	4.47B	4.43B	4.39B	3.98B	3.87B	3.57B	3.45B	3.29B	3.31B	3.29B	3.30B	3.33B	2.20B	2.07B	1.80B	1.63B	1.51B	1.34B	1.46B	1.53B	1.27B	1.15B	1.05B	952.20M	915.00M
Interest Income	23.00M	16.00M	5.00M	5.00M	2.00M	3.00M	6.00M	4.00M	5.00M	4.00M	3.00M	3.00M	3.00M	3.00M	0.00	4.00M	12.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	90.00M	90.00M	106.00M	99.00M	99.00M	97.00M	85.00M	88.00M	88.00M	100.00M	103.00M	122.00M	125.00M	123.00M	139.00M	161.00M	168.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	235.00M	236.00M	224.00M	210.00M	179.00M	182.00M	167.00M	163.00M	165.00M	169.00M	180.00M	182.00M	178.00M	173.00M	185.00M	190.00M	205.00M	192.00M	188.00M	190.00M	197.00M	191.00M	190.00M	225.00M	201.00M	202.00M	137.60M	126.40M	116.50M	103.90M	94.10M	83.60M	89.60M	87.00M	50.10M	44.70M	37.50M	31.40M	27.10M
EBITDA	736.00M	577.00M	928.00M	1.20B	1.46B	1.30B	1.28B	1.28B	1.24B	1.19B	1.16B	1.14B	1.09B	848.00M	1.13B	1.15B	1.05B	1.06B	967.00M	982.00M	973.00M	949.00M	949.00M	835.00M	926.00M	872.00M	798.00M	719.00M	531.50M	463.00M	419.90M	379.90M	345.70M	199.70M	266.60M	251.40M	244.70M	205.20M	201.20M
EBITDA Ratio	10.38%	10.46%	10.03%	18.09%	19.10%	18.04%	18.60%	18.77%	18.59%	18.05%	17.24%	17.34%	16.51%	17.61%	19.30%	18.68%	21.24%	22.08%	20.80%	23.61%	24.77%	25.84%	28.49%	22.96%	25.50%	25.93%	24.52%	23.20%	24.25%	23.13%	22.91%	23.39%	21.33%	12.03%	15.88%	16.31%	18.75%	16.62%	17.92%
Operating Income	916.00M	1.22B	489.00M	1.12B	1.10B	941.00M	1.13B	1.12B	1.06B	1.00B	959.00M	969.00M	903.00M	921.00M	1.09B	1.02B	888.00M	867.00M	779.00M	817.00M	872.00M	855.00M	752.00M	610.00M	780.00M	678.00M	538.10M	466.40M	415.00M	359.10M	325.80M	296.30M	256.10M	112.70M	216.50M	206.70M	207.20M	173.80M	174.10M
Operating Income Ratio	12.91%	16.57%	6.88%	15.22%	16.43%	15.14%	18.37%	18.70%	18.33%	17.70%	17.15%	17.23%	16.51%	17.61%	19.75%	18.68%	16.84%	17.89%	16.77%	18.62%	20.17%	20.63%	18.52%	15.63%	19.10%	16.94%	19.63%	18.42%	18.71%	18.10%	17.74%	18.13%	14.92%	6.84%	14.59%	15.24%	16.45%	15.44%	15.99%
Total Other Income/Expenses	-518.00M	-1.35B	-105.00M	-332.00M	-80.00M	-83.00M	-71.00M	-84.00M	-73.00M	-79.00M	-85.00M	-111.00M	-109.00M	-358.00M	-48.00M	-207.00M	-195.00M	-124.00M	-126.00M	-92.00M	-32.00M	-53.00M	-199.00M	-123.00M	-103.00M	-240.00M	17.90M	32.60M	-44.60M	-21.20M	-19.20M	-21.10M	-45.20M	-26.60M	27.10M	23.00M	4.60M	12.80M	1.20M
Income Before Tax	398.00M	238.00M	607.00M	900.00M	1.19B	1.02B	1.05B	1.03B	983.00M	921.00M	861.00M	853.00M	791.00M	563.00M	925.00M	811.00M	693.00M	743.00M	653.00M	729.00M	840.00M	802.00M	498.00M	487.00M	622.00M	430.00M	472.00M	416.00M	370.40M	337.90M	306.60M	275.20M	210.90M	86.10M	243.60M	229.70M	211.80M	186.60M	175.30M
Income Before Tax Ratio	5.61%	3.22%	8.54%	12.26%	17.63%	16.48%	17.21%	17.29%	17.06%	16.29%	15.40%	15.17%	14.47%	10.76%	16.71%	14.88%	13.14%	15.33%	14.06%	16.61%	19.43%	19.35%	12.26%	12.48%	15.23%	10.74%	17.22%	16.43%	16.70%	17.03%	16.69%	16.84%	12.28%	5.23%	16.42%	16.94%	16.81%	16.57%	16.10%
Income Tax Expense	106.00M	77.00M	136.00M	181.00M	246.00M	204.00M	231.00M	330.00M	335.00M	315.00M	299.00M	279.00M	248.00M	276.00M	322.00M	274.00M	232.00M	247.00M	210.00M	214.00M	294.00M	288.00M	176.00M	162.00M	228.00M	184.00M	174.00M	166.60M	148.30M	137.10M	126.60M	107.30M	93.10M	33.40M	90.00M	84.10M	79.20M	81.70M	79.70M
Net Income	280.00M	149.00M	462.00M	710.00M	939.00M	820.00M	823.00M	701.00M	648.00M	580.00M	558.00M	572.00M	541.00M	557.00M	603.00M	537.00M	461.00M	501.00M	444.00M	1.10B	549.00M	493.00M	322.00M	323.00M	394.00M	246.00M	343.00M	300.00M	222.10M	200.80M	212.10M	167.00M	98.70M	52.70M	153.60M	124.20M	132.60M	104.90M	95.60M
Net Income Ratio	3.95%	2.02%	6.50%	9.67%	13.97%	13.20%	13.44%	11.74%	11.25%	10.26%	9.98%	10.17%	9.89%	10.65%	10.90%	9.85%	8.74%	10.34%	9.56%	24.98%	12.70%	11.90%	7.93%	8.28%	9.65%	6.15%	12.51%	11.85%	10.01%	10.12%	11.55%	10.22%	5.75%	3.20%	10.35%	9.16%	10.52%	9.32%	8.78%
EPS	2.25	1.21	3.75	5.65	7.46	6.42	6.37	5.43	5.01	4.45	4.31	4.37	4.14	4.06	4.28	3.86	3.30	3.31	2.95	6.20	2.59	2.26	1.39	1.37	1.67	0.53	0.73	0.32	1.07	0.95	0.99	0.19	0.12	0.06	0.18	0.14	0.16	0.12	0.06
EPS Diluted	2.24	1.20	3.73	5.58	7.35	6.32	6.25	5.33	4.92	4.37	4.23	4.30	4.09	4.02	4.24	3.81	3.24	3.26	2.90	6.11	2.56	2.23	1.37	1.35	1.64	0.52	0.72	0.31	1.07	0.95	0.99	0.19	0.12	0.06	0.18	0.14	0.15	0.12	0.06
Weighted Avg Shares Out	124.17M	123.59M	123.11M	125.57M	125.83M	127.73M	129.29M	128.95M	129.47M	130.31M	129.56M	131.08M	132.57M	136.70M	140.27M	139.02M	139.63M	151.45M	150.55M	176.59M	211.68M	218.17M	231.85M	236.15M	236.11M	235.36M	469.33M	206.63M	207.74M	212.59M	215.20M	219.40M	218.18M	216.78M	216.13M	221.59M	216.18M	214.21M	213.37M
Weighted Avg Shares Out (Dil)	124.80M	124.18M	123.91M	127.30M	127.67M	129.79M	131.58M	131.57M	131.72M	132.78M	131.74M	132.97M	132.57M	138.10M	141.53M	141.06M	142.00M	153.94M	153.00M	179.18M	214.37M	220.69M	234.70M	239.48M	239.61M	240.00M	479.08M	210.68M	833.12M	852.08M	215.20M	219.40M	218.18M	216.78M	216.13M	221.59M	216.18M	214.21M	213.37M

Clorox Declares Regular Quarterly Dividend of $1.22 Per Share

November 19, 2024prnewswire.com

OAKLAND, Calif. , Nov. 19, 2024 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that its board of directors has declared a quarterly dividend of $1.22 per share on the company's common stock.

Clorox's Turnaround Is Almost Complete. Here's Why the Ultra-Safe Dividend Stock Is Worth Buying Now.

November 18, 2024fool.com

Clorox is perfect for risk-averse investors or retirees looking to supplement income.

5 Defensive Stocks to Counter Volatility as Post-Election Rally Halts

November 15, 2024zacks.com

Low-beta defensive stocks like AGR, ATO, DTE, CLX and INGR are a safe bet during times of market volatility.

Clorox Stock Gains 3.8% in a Week on Solid Q1 Results: Buy or Avoid?

November 6, 2024zacks.com

CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.

Clorox Announces Partnership with M2030 to Advance Supply Chain Climate Action

November 1, 2024prnewswire.com

OAKLAND, Calif. , Nov. 1, 2024 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today a strategic partnership with Manufacture 2030, or M2030, to help Clorox's suppliers meet their carbon reduction targets and advance the company's long-term goal of reaching...

Clorox CEO Linda Rendle goes one-on-one with Jim Cramer

October 31, 2024youtube.com

Clorox Chair and CEO Linda Rendle joins 'Closing Bell Overtime' to talk quarterly results, consumer trends, and more.

We were operating in manual mode for 'nearly two months', says Clorox CEO on cyberattack

October 31, 2024youtube.com

Clorox Chair and CEO Linda Rendle joins 'Closing Bell Overtime' to talk quarterly results, consumer trends, and more.

CLX Q1 Earnings & Sales Beat Estimates, Raised FY25 View Drives Stock

October 31, 2024zacks.com

Clorox's Q1 results reflect a recovery from last year's cyberattack-related woes. Organic sales across all segments and margin expansion boost its performance.

The Clorox Company (CLX) Q1 2025 Earnings Call Transcript

October 30, 2024seekingalpha.com

The Clorox Company (NYSE:CLX ) Q1 2025 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Lisah Burhan - Vice President, Investor Relations Linda Rendle - Chair and CEO Kevin Jacobsen - Chief Financial Officer Conference Call Participants...

Clorox (CLX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

October 30, 2024zacks.com

The headline numbers for Clorox (CLX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

1 2 3 4 5 6 7 8 9 10

Source: https://incomestatements.info
Category: Stock Reports

The Clorox Company (CLX) Income Statement Analysis – Financial Results

Leave a Reply Cancel reply

Recent Posts

Categories